Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
1982-12-3
|
pubmed:language |
rus
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0552-2080
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
27
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3-6
|
pubmed:dateRevised |
2003-11-14
|
pubmed:meshHeading |
pubmed-meshheading:7122455-Animals,
pubmed-meshheading:7122455-Antineoplastic Agents,
pubmed-meshheading:7122455-Ascorbic Acid,
pubmed-meshheading:7122455-Leukemia, Experimental,
pubmed-meshheading:7122455-Mice,
pubmed-meshheading:7122455-Mice, Inbred C57BL,
pubmed-meshheading:7122455-Mice, Inbred Strains,
pubmed-meshheading:7122455-Phenylpropionates
|
pubmed:year |
1982
|
pubmed:articleTitle |
[Effect of ascorbic acid on the formation and leukemogenic action of p-hydroxyphenyllactic acid].
|
pubmed:publicationType |
Journal Article
|